Brandle et al v. McKesson Corporation et al
Filing
25
ORDER REQUESTING ADDITIONAL BRIEFING: All defendants are to file one joint brief no more than ten pages by noon on 3/25/2013. All plaintifs to file one joint brief no more than ten pages by noon on 3/25/2013. Signed by Judge William Alsup on 3/19/2013. (whasec, COURT STAFF) (Filed on 3/19/2013)
1
2
3
4
5
6
IN THE UNITED STATES DISTRICT COURT
7
FOR THE NORTHERN DISTRICT OF CALIFORNIA
8
9
11
For the Northern District of California
United States District Court
10
JAMES BRINDLE, REBECCA GREGG,
and DIANA GUTHRIE,
No. C 12-05970 WHA
Plaintiffs,
12
13
14
15
v.
ORDER REQUESTING
ADDITIONAL BRIEFING
MCKESSON CORPORATION, et al.,
Defendants.
/
16
17
In this pharmaceutical product liability action, plaintiffs move to remand back to state
18
court. Defendants oppose on federal question and supplemental jurisdiction grounds. In PLIVA,
19
Inc. v. Mensing, 131 S.Ct. 2567 (2011), the Supreme Court held that state failure-to-warn claims
20
are preempted by federal law. While “it is now settled law that a case may not be removed to
21
federal court on the basis of a federal defense, including the defense of pre-emption,”
22
Caterpillar Inc. v. Williams, 482 U.S. 386, 393 (1987) (citations omitted) (emphasis in original),
23
there is an “independent corollary.” See id. (citations omitted). “On occasion, the Court has
24
concluded that the pre-emptive force of a statute is so ‘extraordinary’ that it ‘converts an
25
ordinary state common-law complaint into one stating a federal claim for purposes of the well-
26
pleaded complaint rule.’” Id. (quoting Metropolitan Life Ins. Co. v. Taylor, 481 U.S. 58, 65
27
(1987)). Then, “[o]nce an area of state law has been completely pre-empted, any claim
28
purportedly based on that pre-empted state law is considered, from its inception, a federal claim,
1
and therefore arises under federal law.” Id. (quoting Franchise Tax Bd. of State of Cal. v.
2
Constr. Laborers Vacation Trust for S. Cal, 463 U.S. 1, 24 (1983)).
3
4
5
6
This order requests additional briefing on this issue. Specifically, the parties must
address the following three questions:
First, after Mensing, are plaintiffs’ state failure-to-warn claims here “completely
pre-empted” such that federal-question jurisdiction is proper?
7
Second, in the event that federal question jurisdiction is proper, has Congress explicitly
8
authorized a private right of action regarding the labeling of manufacturers of generic drugs or
9
alternatively, has one been implied by law?
Third, what effect (if any) will the Supreme Court’s decision in Mutual Pharm. Co.,
11
For the Northern District of California
United States District Court
10
Inc. v. Bartlett, 133 S.Ct. 694 (2012), granting cert. to Bartlett v. Mutual Pharm. Co., Inc.,
12
678 F.3d 30 (1st Cir. 2012), have on this action?
13
All defendants are to file one joint brief of no more than ten pages by NOON ON
14
MARCH 25, 2013. All plaintiffs are to file one joint brief of no more than ten pages by NOON
15
ON MARCH 25, 2013.
16
17
IT IS SO ORDERED.
18
19
Dated: March 19, 2013.
WILLIAM ALSUP
UNITED STATES DISTRICT JUDGE
20
21
22
23
24
25
26
27
28
2
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?